Karen Dodson's Contact Details

Karen Dodson's Company Details

BlueCube Bio

, , • 5 - 9 Employees
Other

BlueCube Bio is a dynamic startup organization offering fit-for-purpose cryopreservation products and services to academic biologists and cell therapy companies.We are a Delaware S corp founded in June 2020, based on the cutting-edge scientific innovations from Prof. Allison Hubel's Biopreservation Core Resource, University of Minnesota. Inspired by how trees survive Minnesota, BlueCube Bio products are each formulated to optimize the post-thaw survival and performance of its target cell type, so that you don't have to compromise in cryopreservation and its surrounding processes. Our DMSO-free formulations contain only generally-recognized-as-safe ingredients, aimed to de-risk the banking of your cells and ultimately improve the patient experience in cell therapy.The first product, mCube, is designed for the DMSO-free cryopreservation of mesenchymal stromal cells (MSCs). It activates the epigenetic cryoprotective markers and prevents the cytoskeletal damages commonly caused by DMSO. This, in turn, improves not only the post-thaw recovery of MSCs and the cell adhesion but also their cell stability in the cryopreservation media during the non-cryopreserved steps.In addition to mCube, BlueCube Bio offers iCube for pluripotent stem cells.Our research and development team is working on both nkCube for natural killer cells and tCube for T cells. We are in continuous R&D, accelerated by a proprietary platform of investigational technologies, to create new cryopreservation products that meet the needs of this rapidly evolving cell-based research and therapeutic industry.To get scientific support for your cryopreservation work, contact us at team@bluecubebio.com. To learn more about BlueCube Bio, visit our website: www.bluecubebio.com.